TRANSPLANT RECIPIENT (KIDNEY)
Clinical trials for TRANSPLANT RECIPIENT (KIDNEY) explained in plain language.
Never miss a new study
Get alerted when new TRANSPLANT RECIPIENT (KIDNEY) trials appear
Sign up with your email to follow new studies for TRANSPLANT RECIPIENT (KIDNEY), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a bone marrow transplant free kidney patients from lifelong pills?
Disease control Recruiting nowThis early-phase trial tests a combined kidney and bone marrow transplant from the same donor to help the body accept the new kidney without needing lifelong anti-rejection drugs. Up to 12 adults with kidney failure will receive the treatment. The goal is to see if this approach …
Matched conditions: TRANSPLANT RECIPIENT (KIDNEY)
Phase: EARLY_PHASE1 • Sponsor: Tatsuo Kawai, MD, PhD • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Gene test before kidney transplant could prevent drug dosing errors
Disease control Recruiting nowThis study tests whether checking a patient's genes before a kidney transplant can help doctors choose the best starting dose of the anti-rejection drug tacrolimus. About 114 adults on the transplant waiting list will be randomly assigned to either standard dosing or a dose based…
Matched conditions: TRANSPLANT RECIPIENT (KIDNEY)
Phase: PHASE4 • Sponsor: Instituto de Investigación Hospital Universitario La Paz • Aim: Disease control
Last updated Jun 26, 2026 16:21 UTC